+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Sale

Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012190
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Steroid Injections Market grew from USD 4.29 billion in 2024 to USD 4.90 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 9.26 billion by 2030.

A Holistic Introduction to the Steroid Injections Arena

The steroid injections sector has emerged as a critical pillar in the management of musculoskeletal and inflammatory conditions. With rising prevalence of osteoarthritis, rheumatoid arthritis, and various soft tissue disorders, healthcare providers increasingly rely on targeted intra-articular and periarticular steroid therapies to deliver potent anti-inflammatory effects directly to affected tissues. These interventions range from large joint applications within knees and hips to more specialized spinal injections aimed at alleviating nerve root compression. The precision afforded by ultrasound and fluoroscopic guidance continues to enhance clinical outcomes, driving clinician confidence and patient acceptance.

Against this backdrop of expanding clinical utilization, it becomes imperative to comprehensively analyze the market’s evolving contours. This executive summary distills the latest industry developments, regulatory dynamics, tariff implications, and segmentation insights with the goal of equipping decision makers with the actionable intelligence required to navigate complexity. By synthesizing technological innovations, policy shifts, and competitive strategies, this introduction sets the stage for an informed examination of how stakeholders can optimize product portfolios, refine go-to-market approaches, and anticipate future inflection points within the steroid injections landscape.

Unveiling Transformative Shifts Reshaping the Steroid Injection Landscape

Over the past decade, several transformative shifts have recalibrated the steroid injection ecosystem. Technological integration has been instrumental, as real-time imaging guidance has transitioned from niche adoption to standard practice, heightening injection accuracy while reducing adverse events. Concurrently, advanced formulations with extended-release profiles and novel adjuvant combinations have emerged, responding to clinician demand for longer-lasting symptom relief and fewer repeat procedures. These innovations dovetail with a growing emphasis on patient-centric care, where minimally invasive options and accelerated recovery timelines increasingly influence therapeutic selection.

Regulatory frameworks have also evolved, reflecting heightened scrutiny around safety and quality. Stringent manufacturing guidelines for injectables and revised pharmacovigilance requirements for corticosteroids have prompted players to invest in robust compliance infrastructures. At the same time, telemedicine’s rise has expanded remote consultation models, enabling clinicians to triage patients effectively and recommend in-office injections with greater confidence. As digital health platforms mature, they are poised to forge a seamless continuum of care, integrating pre-injection assessment, procedure tracking, and post-injection monitoring.

Assessing the Cumulative Impact of United States Tariffs for 2025

The cumulative impact of United States tariffs slated for 2025 has introduced notable headwinds for steroid injection supply chains. Import duties on active pharmaceutical ingredients have elevated cost bases for manufacturers reliant on overseas API suppliers, prompting many to reassess sourcing strategies. Packaging components and specialized delivery systems have similarly been subject to increased levies, exerting upstream pressure on production expenditures. As cost structures adjust, pricing negotiations with payers and group purchasing organizations have grown more complex, with providers scrutinizing total cost of care and reimbursement carve-outs.

Confronted with these tariff-driven challenges, market participants are accelerating domestic API development investments to mitigate exposure. Some leading firms are forging co-manufacturing partnerships within the U.S. to internalize value chain segments and stabilize margins. Meanwhile, distributors are reengineering logistics flows to optimize landed costs, balancing inventory buffers against working capital constraints. In this environment, strategic agility becomes paramount; stakeholders who can swiftly navigate tariff fluctuations and maintain supply continuity will gain a competitive edge as payers tighten budgets and prioritize cost-effective therapeutic modalities.

Deep Dive into Segmentation Revealing Nuanced Market Patterns

A granular examination of market segmentation reveals differentiated growth trajectories across treatment modalities, therapeutic indications, end users, molecule classes, distribution venues, and patient cohorts. Within treatment type analysis, joint injections in both large and small articulations coexist alongside soft tissue applications targeting bursa, ligament, and tendon pathologies as well as spinal epidural and intrathecal delivery pathways. Each of these modalities presents unique clinical and operational considerations that influence product design and provider preference.

Turning to therapeutic indication, steroids play a pivotal role in addressing back pain subtypes including lower back discomfort, sciatica, and upper back stiffness, in addition to managing bursitis, osteoarthritis, rheumatoid arthritis, and tendonitis. End users span ambulatory surgical centers, orthopedic and pain management clinics, general and specialty hospital settings, each requiring tailored supply chain and service models. The molecule landscape features dexamethasone, hydrocortisone, methylprednisolone, and triamcinolone, with each offering distinct potency, solubility, and safety profiles. Distribution channels traverse hospital pharmacies, online portals, and retail outlets-both chain and independent-while patient demographics extend across adult, geriatric, and pediatric populations. Integrating these categories illuminates nuanced demand drivers and pinpoints areas for targeted value creation.

Regional Dynamics Driving Growth across Key Geographies

The steroid injections market exhibits clear geographic differentiation driven by healthcare infrastructure, reimbursement landscapes, and demographic trends. In the Americas, robust procedural volumes within the U.S. are propelled by advanced imaging adoption and high patient awareness, whereas Latin American markets are characterized by evolving access and growing investment in outpatient surgical capabilities. Across Europe, Middle East and Africa, variations in regulatory approval timelines and public funding models shape utilization rates, with Western Europe leading in reimbursement coverage and emerging Middle Eastern economies demonstrating rapid capital infusion in orthopedic centers.

Asia-Pacific dynamics reflect a dual trajectory: established markets such as Japan and Australia are marked by stringent safety standards and mature specialty clinic networks, while China, India, and Southeast Asia register escalating demand for minimally invasive interventions amid rising incidence of musculoskeletal disorders. These regions offer substantial growth potential, underpinned by expanding insurance penetration and improving procedural reimbursement. As regional payers and policymakers refine coverage policies, stakeholders can leverage precise market entry strategies to capture latent demand and optimize resource allocation.

Competitive Landscape Spotlight Highlighting Leading Players

Major pharmaceutical and medical device firms are intensifying research and commercial efforts in the steroid injections arena. Legacy players with deep formulation expertise have broadened portfolios to include extended-release corticosteroids and combination therapies. Emerging specialists are forging alliances with imaging technology providers to bundle injection kits with integrated guidance solutions. Additionally, contract manufacturing organizations are expanding sterile injectable capacity to support scale-up needs, while distribution networks are consolidating to enhance supply chain resilience.

Strategic collaborations between biopharmaceutical innovators and orthopedic device manufacturers reflect a trend toward value-based propositions, where procedure efficacy and patient satisfaction metrics drive adoption. Competitive differentiation increasingly hinges on service offerings such as clinician training programs, digital injection tracking platforms, and patient support initiatives. Companies that can harmonize product performance with comprehensive care pathways will set new benchmarks in market penetration and brand loyalty.

Strategic Recommendations to Capitalize on Emerging Opportunities

Industry leaders should prioritize investments in advanced formulation research and real-time navigation technologies to differentiate their offerings and elevate clinical efficacy. Strengthening domestic API production capabilities will buffer against trade policy volatility and foster greater supply continuity. Engaging payers through robust pharmacoeconomic evidence-demonstrating cost savings from reduced procedure frequency and short-term hospital stays-can unlock favorable reimbursement pathways.

Expanding clinician education initiatives across orthopedic, neurology, and pain specialty networks will accelerate uptake of new injection protocols. Tailoring patient outreach through digital platforms that offer pre-procedure guidance and post-injection monitoring can enhance adherence and generate real-world evidence. Finally, forging strategic partnerships with ambulatory surgical centers and specialty clinics can streamline distribution, amplify co-marketing opportunities, and create integrated care models that resonate with value-based healthcare stakeholders.

Rigorous Research Methodology Underpinning Insights

This analysis was underpinned by a structured methodology combining primary interviews with industry executives, clinicians, and supply chain specialists alongside secondary research encompassing peer-reviewed journals, regulatory filings, and market intelligence databases. Data points were triangulated to ensure consistency across sources, with outliers subjected to further validation through targeted expert consultations. The segmentation framework was developed to reflect both clinical use cases and commercial channels, enabling a holistic view of market dynamics.

Rigorous quality checks were applied at every stage, including cross-referencing tariff schedules, policy announcements, and competitor filings to accurately capture the cumulative impact of trade measures. Regional insights were honed through country-level assessments of procedural volumes, reimbursement structures, and growth enablers. The result is a comprehensive, evidence-based perspective designed to inform strategic decision making and guide stakeholders through an increasingly complex operating environment.

Synthesis of Insights and Forward Looking Perspectives

In synthesizing the multifaceted drivers of the steroid injections market, this report illuminates the interplay between technological innovation, regulatory evolution, trade policy, and competitive strategy. The integration of segmentation and regional analyses reveals targeted opportunities for value creation, while the exploration of tariff impacts underscores the importance of supply chain resilience. Stakeholders equipped with these insights can refine their strategic roadmaps, optimize resource deployment, and anticipate forthcoming shifts in clinical practice and policy regimes.

As the market continues to evolve, ongoing vigilance around pipeline developments, partnership models, and reimbursement trends will be essential. By leveraging the structured intelligence presented herein, decision makers can position their organizations to thrive amid both current challenges and future inflection points.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Joint Injections
      • Large Joints
      • Small Joints
    • Soft Tissue Injections
      • Bursa Injections
      • Ligament Injections
      • Tendon Injections
    • Spinal Injections
      • Epidural
      • Intrathecal
  • Therapeutic Indication
    • Back Pain
      • Lower Back Pain
      • Sciatica
      • Upper Back Pain
    • Bursitis
    • Osteoarthritis
    • Rheumatoid Arthritis
    • Tendonitis
  • End User
    • Ambulatory Surgical Centers
    • Clinics
      • Orthopedic Clinics
      • Pain Management Clinics
    • Hospitals
      • General Hospitals
      • Specialty Hospitals
  • Molecule Type
    • Dexamethasone
    • Hydrocortisone
    • Methylprednisolone
    • Triamcinolone
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • Patient Type
    • Adult
    • Geriatric
    • Pediatric
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bayer AG
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Steroid Injections Market, by Treatment Type
8.1. Introduction
8.2. Joint Injections
8.2.1. Large Joints
8.2.2. Small Joints
8.3. Soft Tissue Injections
8.3.1. Bursa Injections
8.3.2. Ligament Injections
8.3.3. Tendon Injections
8.4. Spinal Injections
8.4.1. Epidural
8.4.2. Intrathecal
9. Steroid Injections Market, by Therapeutic Indication
9.1. Introduction
9.2. Back Pain
9.2.1. Lower Back Pain
9.2.2. Sciatica
9.2.3. Upper Back Pain
9.3. Bursitis
9.4. Osteoarthritis
9.5. Rheumatoid Arthritis
9.6. Tendonitis
10. Steroid Injections Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Orthopedic Clinics
10.3.2. Pain Management Clinics
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialty Hospitals
11. Steroid Injections Market, by Molecule Type
11.1. Introduction
11.2. Dexamethasone
11.3. Hydrocortisone
11.4. Methylprednisolone
11.5. Triamcinolone
12. Steroid Injections Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. Steroid Injections Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Americas Steroid Injections Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Steroid Injections Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Steroid Injections Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Novartis AG
17.3.3. Sanofi S.A.
17.3.4. Bayer AG
17.3.5. Johnson & Johnson
17.3.6. AbbVie Inc.
17.3.7. Merck & Co., Inc.
17.3.8. Roche Holding AG
17.3.9. Teva Pharmaceutical Industries Ltd.
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STEROID INJECTIONS MARKET MULTI-CURRENCY
FIGURE 2. STEROID INJECTIONS MARKET MULTI-LANGUAGE
FIGURE 3. STEROID INJECTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 86. CANADA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 87. CANADA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 88. CANADA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 90. CANADA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 92. CANADA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. CANADA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CANADA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. CANADA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 103. MEXICO STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 165. GERMANY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 169. GERMANY STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. GERMANY STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 171. GERMANY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. GERMANY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. GERMANY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 182. FRANCE STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. FRANCE STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. FRANCE STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. FRANCE STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. FRANCE STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ITALY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 204. ITALY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 205. ITALY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 206. ITALY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 207. ITALY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 208. ITALY STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ITALY STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. ITALY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. ITALY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 212. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. ITALY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. ITALY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 217. SPAIN STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SPAIN STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 221. SPAIN STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SPAIN STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. SPAIN STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 225. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SPAIN STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. SPAIN STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 272. DENMARK STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 273. DENMARK STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. DENMARK STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. DENMARK STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. DENMARK STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 295. QATAR STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 296. QATAR STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 297. QATAR STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 298. QATAR STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 299. QATAR STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. QATAR STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. QATAR STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. QATAR STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 303. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. QATAR STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 305. QATAR STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 306. FINLAND STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. FINLAND STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 308. FINLAND STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 309. FINLAND STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 311. FINLAND STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 312. FINLAND STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. FINLAND STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 314. FINLAND STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. FINLAND STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 316. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. FINLAND STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. FINLAND STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA STEROID INJECTIONS MARKET SIZE

Companies Mentioned

The companies profiled in this Steroid Injections market report include:
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bayer AG
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.26 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Joint Pain Injections Market Report 2025 - Product Image

Joint Pain Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Joint Pain Injections Market by Molecule Type, Indication, Route Of Administration, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030 - Product Image

Joint Pain Injections Market by Molecule Type, Indication, Route Of Administration, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Ropivacaine Hydrochloride & Sodium Chloride Injection Market by Application Type, Formulation, End User, Dosage Strength, Distribution Channel - Global Forecast to 2030 - Product Image

Ropivacaine Hydrochloride & Sodium Chloride Injection Market by Application Type, Formulation, End User, Dosage Strength, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From

About the Steroid Injections Market

The steroid injections market is a subset of the broader infusions and injectables sector, focusing on products that deliver steroids directly into the body tissues, including joints, muscles, and the spine. Steroids, which are synthetic drugs that closely resemble cortisol, a hormone that the body produces naturally, are used to reduce inflammation and suppress the immune system. They are commonly prescribed for a range of conditions including arthritis, back pain, and various inflammatory diseases. The market comprises a variety of steroid types, including cortisone, methylprednisolone, and triamcinolone, among others. These injections are often administered in outpatient settings like clinics and hospitals by healthcare professionals, including doctors and nurses, who are skilled in performing these procedures. The sector is influenced by factors such as the prevalence of chronic diseases, advancements in drug formulations, and improvements in administration techniques, providing patients with pain management and symptomatic relief options. Some notable players in the steroid injections market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, and Bristol-Myers Squibb Company. These companies are engaged in the production and distribution of steroid injectables and continuously invest in research and development to improve the efficacy and safety profiles of their products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.